Phase I and pharmacokinetic study of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) using a single intravenous dose schedule

Lynn Feun, Manuel Modiano, King Lee, John Mao, Angela Marini, Niramol Savaraj, Patricia Plezia, Bijan Almassian, Elizabeth Colacino, Jessica Fischer, Susan MacDonald

Research output: Contribution to journalArticle

98 Scopus citations

Fingerprint Dive into the research topics of 'Phase I and pharmacokinetic study of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) using a single intravenous dose schedule'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences